Growth Factor Cocktail Including Fibroblast Growth Factor 9 in the Treatment of Androgenetic Alopecia in Men and Women: A Randomized Controlled Trial
July 2023
in “
International journal of trichology
”
Studysummary In this randomized controlled trial, researchers found that Cellcurin therapy significantly increased hair density, terminal hair, and vellus hair counts in men and women with androgenetic alopecia, compared to minoxidil control, over 12 weeks.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on journals.lww.com →